The assessment that the statement is likely true is based on a convergence of high-authority evidence with no contradictions. The most definitive piece of evidence is the primary source from MicroStrategy itself, an official press release that directly states a net loss of $12.4 billion for Q4 2025. This claim is independently and consistently corroborated by multiple reputable secondary sources, including financial news publications like TheStreet and financial data platforms like TipRanks and Coinspeaker, all of which cite the company's official announcement. Additional sources reinforce the verifiability of the claim by pointing to official SEC filings. The two sources concerning an unrelated company, Novo Nordisk, are correctly identified as irrelevant and do not impact the assessment. The complete lack of conflicting information across all relevant sources, combined with the strength and consistency of the primary and secondary evidence, leads to a high confidence conclusion that the statement is true.